Micafungin in the treatment of invasive fungal infection in an infant with extracorporeal

Enferm Infecc Microbiol Clin. 2017 Aug-Sep;35(7):466-467. doi: 10.1016/j.eimc.2016.10.005. Epub 2016 Nov 16.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antifungal Agents
  • Biofilms / drug effects
  • Candida tropicalis / drug effects
  • Candida tropicalis / isolation & purification*
  • Candida tropicalis / physiology
  • Candidemia / drug therapy*
  • Candidemia / etiology
  • Candidemia / microbiology
  • Combined Modality Therapy
  • Cross Infection / drug therapy*
  • Cross Infection / etiology
  • Cross Infection / microbiology
  • Equipment Contamination
  • Extracorporeal Membrane Oxygenation / adverse effects*
  • Female
  • Humans
  • Infant
  • Micafungin
  • Pneumonia, Necrotizing / complications
  • Pneumonia, Necrotizing / drug therapy
  • Pneumonia, Necrotizing / therapy
  • Pneumonia, Pneumococcal / complications
  • Pneumonia, Pneumococcal / drug therapy
  • Respiration, Artificial
  • Respiratory Distress Syndrome / etiology
  • Respiratory Distress Syndrome / therapy
  • Shock, Septic / etiology
  • Shock, Septic / therapy*
  • Superinfection / drug therapy
  • Superinfection / etiology*
  • Superinfection / microbiology

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Micafungin